DexCom Inc. | Mutual Funds
Mutual Funds that own DexCom Inc.
Vanguard Small Cap Index Fund
2,105,410
2.38%
27,616
0.31%
07/31/2018
Vanguard Total Stock Market Index Fund
2,104,176
2.38%
9,064
0.04%
07/31/2018
Morgan Stanley Instl. Fund-Growth Portfolio
1,522,387
1.72%
263,633
3.73%
06/30/2018
American Funds Small Cap World Fund
1,503,000
1.7%
0
0.56%
06/30/2018
Oppenheimer International Small Company Fund
1,483,700
1.68%
0
2.04%
02/28/2018
T Rowe Price New Horizons Fund
1,297,600
1.47%
-770,400
0.77%
06/30/2018
Vanguard Small Cap Growth Index Fund
1,202,031
1.36%
17,884
0.67%
07/31/2018
Vanguard Extended Market Index Fund
1,166,051
1.32%
6,305
0.23%
07/31/2018
Janus Enterprise Fund
1,150,056
1.3%
-218,807
0.86%
06/30/2018
T Rowe Price Mid Cap Growth Fund
1,125,000
1.27%
-625,000
0.49%
06/30/2018
| Address |
6340 Sequence Drive
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.dexcom.com |
| Updated |
07/08/2019 |
| DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps. The company was founded by John F. |
